APLS Message Board Post 8721734 | Apellis Pharmaceuticals...
home / stock / apls / apls message board
when-d
(investorshub)
Posted on: Apr/18/2023 06:49:25
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168708654
Price gaining up
News, Short Squeeze, Breakout and More Instantly...
Apellis Pharmaceuticals Inc. Company Name:
APLS Stock Symbol:
Market:
-
Apellis received $375 million in funding at close, with ability to access an additional $100 million Majority of initial proceeds used to buy out...
-
Apellis received $375 million in funding at close, with ability to access an additional $100 million Majority of initial proceeds used to buy out existing SFJ Pharmaceuticals development liability Significantly improves liquidity profile by eliminating $366 million in SFJ payments...
-
Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA no later than J...